Healthcare

Mesoblast was the top gainer on the ASX today; Let’s find out why

COVID-19 turmoil is a public health crunch, with staggering fatalities and human suffering beyond words. This unprecedented crisis is being deeme...

ASX-listed Dental Stocks: Is there any relief coming in? PSQ, ONT, S...

Due to the rising number of coronavirus infections, many businesses were shut down amid COVID-19-induced restrictions. At the same time, some business...

ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HR...

The healthcare sector across the world is struggling with the myriad challenges thrown by the COVID-19 pandemic, and virtual healthcare is fast becomi...

ASX biotech companies creating a pandemic-free buzz!

As on 19 June 2020, the “pneumonia-like” illness has taken 456,432 lives with 8,538,928 confirmed cases recorded worldwide.  And with...

Are Investors Buying these Healthcare Stocks: Starpharma, Sigma and...

The healthcare sector is a significant and complex sector comprising a variety of companies engaged in manufacturing, developing, and selling of medic...

Don’t Miss! Small-Cap Healthcare Players’ Continued Focus on Innovat...

In the healthcare world, the general trend has been that smaller biotech players work on the innovation angle with research and development activities...

3 Small-cap Healthcare Stocks to Watch Out For – IMM, IDX, AT1

Small-cap stocks are listed companies with market capitalisation varying from USD 300 million to USD 2 billion or less. And in these stocks, there are...

Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASC...

Summary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at AS...

Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2...

Australian based clinical-stage Oncology company Prescient Therapeutics Limited (ASX:PTX), recently reported operating highlights and financial outcom...

Lens over SUDA’s Operational Highlights in 1H FY20

Continuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA Pharmaceuticals Ltd (ASX:SUD) has recently declar...

A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx

It’s surely a prosperous new year for the clinical-stage immuno-oncology player, Imugene Limited (ASX:IMU) that has received core US patent in t...

Prescient Collaborates with Carina Biotech in Expansion into Excitin...

Prescient Therapeutics Limited (ASX: PTX) develops personalised medicine approaches to address mutations that cause cancer. The Company employs a targ...

Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics

Health care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology....

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Mark...

Imugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to ena...

Journey of Prescient Therapeutics in 2019

Prescient Therapeutics Limited (ASX: PTX) is a clinical-stage oncology company that works on mutation causing cancer. The existing product portfolio o...

Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ D...

Noxopharm Limited (ASX: NOX) has released July 2019 edition of its Newsletter called 'Versatility'. The clinical-stage drug development company, Noxo...

An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials

An Australian-based biotechnology company, Imugene Limited (ASX: IMU) focuses on the development of cancer immunotherapies targeted at activating the...

A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Im...

An Australian-headquartered clinical stage immuno-oncology company, Imugene Limited (ASX: IMU) has a robust pipeline of B cell vaccines aimed at treat...

AFP’s FY19 Performance - What investors need to know?

AFT Pharmaceuticals Limited (ASX: AFP) is a growing pharma company with its head office based out of New Zealand. It officially was listed on ASX in D...

Kazia Therapeutics collaborates with Alliance to investigate new dru...

Kazia Therapeutics Limited (ASX: KZA) caters to the health care sector and is based out of Sydney, Australia. It is a bio-tech company which focusses...